Background Neonatal hypoxic–ischemic encephalopathy is an important cause of death as
well as long-term disability in survivors. Erythropoietin has been hypothesized to have …

Background The use of cerebral oximetry monitoring in the care of extremely preterm infants
is increasing. However, evidence that its use improves clinical outcomes is lacking. …

Background High-dose erythropoietin has been shown to have a neuroprotective effect in
preclinical models of neonatal brain injury, and phase 2 trials have suggested possible efficacy…

Importance Extremely preterm (EP) infants frequently receive opioids and/or benzodiazepines,
but these drugs’ association with neurodevelopmental outcomes is poorly understood. …

Importance The ability to predict neurodevelopmental impairment (NDI) for infants diagnosed
with hypoxic ischemic encephalopathy (HIE) is important for parental guidance and clinical …

Intrauterine growth restriction (IUGR) increases the risk of serious adult morbidities such as
hypertension. In an IUGR rat model of hypertension, we reported a persistent decrease in …

Catheterization of the aorta through the umbilical artery and/or of peripheral arteries in
neonates may be accompanied by a number of complications, of which thrombotic phenomena …

Background: Despite therapeutic hypothermia, neonates with encephalopathy (NE) have high
rates of death or disability. Darbepoetin alfa (Darbe) has comparable biological activity to …

Importance Extremely preterm infants are among the populations receiving the highest levels
of transfusions. Erythropoietin has not been recommended for premature infants because …

Objective To examine the frequency of placental abnormalities in a multicenter cohort of
newborn infants with hypoxic–ischemic encephalopathy (HIE) and to determine the association …